Squamous Cell Carcinoma of the Head and Neck
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Head and Neck.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. [Phase 1]
Phase 1 trial evaluating safety and activity of 177Lu-3BP-227 in solid tumours expressing neurotensin receptor type 1; study terminated with…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck [Phase 2]
Phase 2 trial evaluating valproic acid in combination with cisplatin and cetuximab for recurrent or metastatic squamous cell carcinoma of th…
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Biomarker-based Study in R/M SCCHN [Phase 2]
Phase 2 biomarker-based study in recurrent/metastatic squamous cell carcinoma of the head and neck is ongoing with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Study of LN-145/LN-145-S1 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & Neck [Phase 2]
A Phase 2 clinical trial evaluating LN-145/LN-145-S1 autologous tumor infiltrating lymphocytes for squamous cell carcinoma of the head and n…
-
CLINICAL_TRIALS trial_result · 2023-08-31Clinical Trial Update: Feasibility & Efficacy of Durvalumab+Tremelimumab+RT and Durvalumab+RT in Non-resect. Locally Advanced HPVnegativ HNSCC [Phase 2]
Phase 2 trial assessing feasibility and efficacy of Durvalumab+Tremelimumab+radiation therapy and Durvalumab+radiation therapy in non-resect…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN [Phase 2]
Phase 2 trial evaluating SBRT with cetuximab, with or without docetaxel, followed by adjuvant cetuximab +/- docetaxel in recurrent, previous…
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer [Phase 1]
Phase 1 clinical trial evaluating Panitumumab-IRDye800 and 89Zr-Panitumumab imaging agents for identifying metastatic lymph nodes in patient…
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: NIVolumab in Subjects With Recurrent or Metastatic Platinum-refrACTORy SCCHN [Phase 3]
Phase 3 trial update for NIVolumab in recurrent/metastatic platinum-refractory squamous cell carcinoma of the head and neck has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN [Phase 3]
Phase 3 trial comparing MRG003 to Cetuximab/Methotrexate in recurrent/metastatic squamous cell carcinoma of the head and neck is ongoing wit…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCC [Phase 2]
Phase 2 trial investigating tolerance and efficacy of pembrolizumab or cetuximab with radiotherapy in locally advanced head and neck squamou…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors [Phase 1]
Phase 1 trial update on an arginase-1 peptide vaccine in patients with metastatic solid tumors, including non-small cell lung cancer and uro…
-
CLINICAL_TRIALS trial_result · 2023-01-18Clinical Trial Update: Nivolumab in Recurrent and/or Metastatic SCCHN [Phase 2]
Phase 2 trial update for nivolumab in recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN) that is platinum-refractory,…
-
CLINICAL_TRIALS trial_result · 2022-12-30Clinical Trial Update: Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN [Phase 1, Phase 2]
Clinical trial investigating SNS-301 in combination with checkpoint inhibitors for metastatic/recurrent squamous cell carcinoma of the head …
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: A Randomized Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and Neck [Phase 2]
A randomized Phase II trial evaluating optimization of immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck…
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer [Phase 2]
Phase 2 trial comparing panitumumab-IRDye800 imaging against sentinel node biopsy and selective neck dissection for identifying metastatic l…
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN [Phase 2]
Phase 2 trial evaluating neoadjuvant nivolumab and lirilumab, followed by surgery and adjuvant nivolumab and lirilumab for squamous cell car…
-
CLINICAL_TRIALS trial_result · 2022-04-21Clinical Trial Update: Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 trial evaluating nivolumab plus ipilimumab versus nivolumab plus ipilimumab placebo in recurrent or metastatic squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: Comparison of Two Concomitant Administration of RT With Cisplatin in Standard Infusion or Fractional Infusion [Phase 2]
Phase 2 trial comparing two concomitant administration methods of radiotherapy with cisplatin in standard vs fractional infusion for squamou…
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 trial evaluating re-irradiation with fractionated stereotactic radiosurgery plus cetuximab in patients with recurrent squamous cell …
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety study of tisotumab vedotin (HuMax®-TF-ADC) in patients with solid tumors completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports results for durvalumab (MEDI4736) in combination with AZD9150 or AZD5069 in patients with advanced…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. [Phase 2]
Phase 2 clinical trial update on tisotumab vedotin with continued treatment in patients with various solid tumors, including gynecologic and…
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: SHR-1701 in Patients With Recurrent/Metastatic Scchn [Phase 2]
Phase 2 clinical trial update for SHR-1701 in recurrent/metastatic squamous cell carcinoma of the head and neck.
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Clinical trial update for avelumab in combination with bempegaldesleukin with or without talazoparib or enzalutamide in advanced solid tumor…
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer [Phase 3]
Phase 3 trial evaluating nivolumab alone or with cisplatin plus radiotherapy in cisplatin-eligible or -ineligible locally advanced squamous …